News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>UBS: HKEX (00388.HK) 4Q25 Results Beat but TP Cut to HKD462
UBS published a report on HKEX (00388.HK), which beat expectations for its 4Q25 results, with revenue growing 15% YoY to HKD7.3 billion, approximately 9% above consensus. This was ...
Reset
Send
The window will close in 5 seconds
<Research>UBS: HKEX (00388.HK) 4Q25 Results Beat but TP Cut to HKD462
Close
Recommend
8
Positive
12
Negative
3
 
 

UBS published a report on HKEX (00388.HK)  -4.400 (-1.099%)    Short selling $293.33M; Ratio 106.963%   , which beat expectations for its 4Q25 results, with revenue growing 15% YoY to HKD7.3 billion, approximately 9% above consensus. This was attributed to stronger NII and depository & custody fees

HKEX's net profit added 15% YoY to HKD4.3 billion, about 15% ahead of consensus, thanks to effective cost control. Looking ahead, HKEX seeks to invest in growth while maintaining cost discipline. In 1Q26, HKEX will face a tougher base.

Related News G Sachs Lowers TP for MSCI China Index and CSI 300 Index by 5% and 4%, Still Recommends Overweight on A Shares and H Shares
The broker fine tuned its EPS forecasts for 2026, 2027, and 2028, increasing by 3%, decreasing by 2%, and decreasing by 3% to HKD13.3, HKD12.9, and HKD13.8, respectively. The broker adjusted the target price from HKD471 to HKD462, and maintained a Neutral rating.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.